Global Digital Breast Tomosynthesis (DBT) Equipment Market Poised for Robust Growth, Projected to Reach USD 9,495.1 Million by 2033 at a 13.9% of CAGR

Global Digital Breast Tomosynthesis (DBT) Equipment Market

The global digital breast tomosynthesis (DBT) equipment market is set for rapid growth, with an estimated compound annual growth rate (CAGR) of 13.9% from 2023 to 2033. Valued at USD 2,594.4 million in 2023, the market is projected to reach USD 9,495.1 million by 2033, fueled by the increasing prevalence of breast cancer and the growing need for accurate screening and diagnostic tools.

Digital breast tomosynthesis, or 3D breast tomosynthesis, represents a breakthrough in breast cancer detection technology. By capturing a series of 2D images and reconstructing them into a 3D view, DBT enables radiologists to detect breast cancer more precisely, especially in women with dense breast tissue. Compared to traditional mammography, which provides only 2D images, DBT significantly reduces the risk of false positives and enhances diagnostic accuracy.

This advanced technology has become a preferred choice in breast cancer screening programs worldwide, offering a higher detection rate and increased reliability for early diagnosis. As breast cancer cases continue to rise, the demand for digital breast tomosynthesis equipment is expected to grow, encouraging manufacturers to expand production capacities and invest in R&D for further technological advancements.

Key Highlights of the Digital Breast Tomosynthesis (DBT) Equipment Industry

• Due to increased awareness and demand for advanced breast cancer screening, the digital breast tomosynthesis equipment market is expanding rapidly.
• DBT equipment’s technological developments foster digital breast tomosynthesis (DBT) equipment market expansion and enhance breast cancer early detection rates.
• As healthcare providers attempt to improve diagnostic accuracy and lower false positives, DBT equipment adoption is rising globally.
• Accessibility to advanced breast cancer screening is being improved by market growth for cost-effective DBT equipment solutions.
• Market trends point to a move toward 3D mammography, with DBT equipment setting the standard in breast imaging.

Competitive Analysis

The digital breast tomosynthesis equipment market is strongly competitive, with many businesses fighting for market share. Leading digital breast tomosynthesis equipment manufacturers use tactics like innovation, research and development investments, and collaborations to preserve their competitive advantage.

New digital breast tomosynthesis (DBT) equipment manufacturers are joining the market with creative solutions, escalating the rivalry and accelerating the development of DBT equipment. The rising demand for breast cancer screening options fuels the digital breast tomosynthesis (DBT) equipment industry’s competitive dynamics.

Vital Digital Breast Tomosynthesis (DBT) Equipment Manufacturers

• GE Healthcare
• Siemens Healthineers
• Hologic Inc.
• Canon Medical
• FUJIFILM Holdings Corporation
• General Electric Company
• Internazionale Medico Scientifica
• PLANMED OY
• Analogic Corporation
• Trivitron Healthcare

Get Full Report Now

Key Segments

By Product:

• 3-D Equipment
• 3-D Upgradation

By End User:

• Hospitals
• Diagnostic Centres

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube